leisure time -WSS

leisure time

author：fashion 2025-10-01 18:23:48 - browse：984

Are there still too many biotech companies? How do you know when you’re in a bubble? And is there a wrong way to pronounce “TIGIT”?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Josh Schimmer and Eric Schmidt, two longtime analysts teaming up at Cantor Fitzgerald, join us for a back-to-school conversation as biotech enters the busy back third of 2023. We also discuss the latest news in the life sciences, including some scientific evolution at Biogen, new leadership at Illumina, and the future of CRISPR medicine.

For more on what we cover, here’s the news from Biogen; here’s more on Illumina; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： How Brent Saunders' Allergan experiment failed

WSS

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

The aspartame in Diet Coke probably isn’t giving you cancer

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

hotspot

leisure time

entertainment

Bright Health sells Medicare Advantage business to Molina

The aspartame in Diet Coke probably isn’t giving you cancer

Activists slam private health insurers over coverage restrictions

The aspartame in Diet Coke probably isn’t giving you cancer

Cancer drug shortages should be causing more outrage

Biden White House, tech companies launch new safeguards around emerging AI technology

Medicare details structure of new drug price negotiation program

Biden targets hefty hospital 'facility fees' that often surprise patients

Apple is now the first public company to be valued at $3 trillion

New chart reveals military’s vast involvement in Operation Warp Speed

focus

Wisconsin governor employs partial veto to fund schools for 4 centuries

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Florida babysitter arrested over hot car death, authorities say

Home health providers sue Medicare over payment cuts

What is the Turing Test that determines if computers can think?

Biden declares emergency in flood

entertainment

entertainment

entertainment

focus